Allspring Global Investments’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,975
| Closed | -$231K | – | 1802 |
|
|
2024
Q4 | $231K | Sell |
5,975
-97,867
| -94% | -$3.78M | ﹤0.01% | 1647 |
|
|
2024
Q3 | $4.67M | Buy |
103,842
+103,414
| +24,162% | +$4.65M | 0.01% | 962 |
|
|
2024
Q2 | $14.8K | Sell |
428
-1,542
| -78% | -$53.4K | ﹤0.01% | 2164 |
|
|
2024
Q1 | $57K | Sell |
1,970
-563
| -22% | -$16.3K | ﹤0.01% | 1923 |
|
|
2023
Q4 | $58.1K | Sell |
2,533
-5,973
| -70% | -$137K | ﹤0.01% | 1862 |
|
|
2023
Q3 | $142K | Sell |
8,506
-167,023
| -95% | -$2.79M | ﹤0.01% | 1863 |
|
|
2023
Q2 | $4.85M | Sell |
175,529
-48,135
| -22% | -$1.33M | 0.01% | 1011 |
|
|
2023
Q1 | $5.14M | Buy |
223,664
+217,761
| +3,689% | +$5.01M | 0.01% | 983 |
|
|
2022
Q4 | $64.4K | Sell |
5,903
-5,784
| -49% | -$63.1K | ﹤0.01% | 2233 |
|
|
2022
Q3 | $98K | Buy |
11,687
+1,375
| +13% | +$11.5K | ﹤0.01% | 2089 |
|
|
2022
Q2 | $81K | Sell |
10,312
-16,994
| -62% | -$133K | ﹤0.01% | 2123 |
|
|
2022
Q1 | $646K | Buy |
27,306
+1,935
| +8% | +$45.8K | ﹤0.01% | 2111 |
|
|
2021
Q4 | $867K | Buy |
+25,371
| New | +$867K | ﹤0.01% | 2026 |
|